These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10023900)

  • 1. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
    Maddison P; Newsom-Davis J; Mills KR; Souhami RL
    Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
    Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
    Sher E; Comola M; Nemni R; Canal N; Clementi F
    Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
    Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
    Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
    Komai K; Iwasa K; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
    [No Abstract]   [Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
    Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
    J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
    Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
    J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
    Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
    [No Abstract]   [Full Text] [Related]  

  • 15. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma.
    Small S; Ali HH; Lennon VA; Brown RH; Carr DB; de Armendi A
    Anesthesiology; 1992 Jan; 76(1):142-5. PubMed ID: 1309626
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
    Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
    J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
    Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
    Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
    Sher E; Carbone E; Clementi F
    Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
    [No Abstract]   [Full Text] [Related]  

  • 20. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
    Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
    J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.